[PBSCT and GVHD]
- PMID: 10475037
[PBSCT and GVHD]
Abstract
Allogeneic peripheral blood stem cell transplantation (PBSCT) has been increasingly used as an alternative to allogeneic bone marrow transplantation. Allo-PBSCT can provide rapid engraftment of neutrophils and platelets. Although the recipients of allogeneic PBSCT are infused 10-fold T cells compared with BMT, there is no evidence for a significant difference between PBSCT and BMT with regard to incidence and severity of acute graft-versus-host disease (GVHD). On the other hand, several reports have indicated a high risk for developing chronic GVHD after allogeneic PBSCT as opposed to BMT.
Similar articles
-
[Allogeneic peripheral blood stem cell transplantation].Gan To Kagaku Ryoho. 1996 Dec;23(14):1877-85. Gan To Kagaku Ryoho. 1996. PMID: 8978790 Review. Japanese.
-
Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.Biol Blood Marrow Transplant. 2008 Mar;14(3):301-8. doi: 10.1016/j.bbmt.2007.12.491. Biol Blood Marrow Transplant. 2008. PMID: 18275896
-
Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.Br J Haematol. 2004 May;125(4):480-93. doi: 10.1111/j.1365-2141.2004.04943.x. Br J Haematol. 2004. PMID: 15142119
-
[CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].Rinsho Ketsueki. 2000 Jun;41(6):500-6. Rinsho Ketsueki. 2000. PMID: 10921350 Japanese.
-
[Allogeneic peripheral blood stem cell transplantation].Rinsho Byori. 1999 May;Suppl 110:85-91. Rinsho Byori. 1999. PMID: 10475036 Review. Japanese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources